NINA GAGNIER: Open Payments
NPI 1689219990 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$211 in 8 payments from 6 companies in 2025. Trend: 2023 $205 · 2024 $143 · 2025 $211
Food & beverage: $211
| Company | Payments | Amount |
|---|---|---|
| ACADIA Pharmaceuticals Inc | 1 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $45 |
| Neurocrine BioSciences, Inc. | 2 | $41 |
| Alpha Cognition USA, Inc. | 1 | $28 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
Products named: NUPLAZID, REXULTI, INGREZZA, Zunveyl, AUSTEDO XR, Qelbree.
Industry payments across FL — which companies pay providers there.
